SKI-178: A Multitargeted Inhibitor of Sphingosine Kinase and Microtubule Dynamics Demonstrating Therapeutic Efficacy in Acute Myeloid Leukemia Models.Novel pharmacological maps of protein lysine methyltransferases: key for target deorphanizationNetwork-Based Assessment of Adverse Drug Reaction Risk in Polypharmacy Using High-Throughput Screening DataZafirlukast Is a Dual Modulator of Human Soluble Epoxide Hydrolase and Peroxisome Proliferator-Activated Receptor γOff Target But on Track to New Strategies to Mitigate Calcific Aortic Valve DiseaseMultidisciplinary approaches for targeting the secretase protein family as a therapeutic route for Alzheimer's diseaseDrug repurposing in oncology: Compounds, pathways, phenotypes and computational approaches for colorectal cancer
P921
Q41521563-0124EFF6-811D-4350-8ED1-16295EC89C29Q61780680-DA638772-76FE-41AD-B849-D0B50394B245Q61814456-E313CB64-ECE1-49C2-9E82-2B0AA429C681Q64070172-5D008622-600B-4508-AE9D-474FE0590B40Q64081778-B6B00576-2089-435A-AB52-F71F230F15ADQ64118737-D119BBA6-3CE6-4A71-A1A0-0F793B4CC52DQ64272815-851DA934-E55C-4A37-A7E8-3DC228276610
P921
description
design or use of pharmaceutical agents
@en
name
Polifarmacologia
@ca
Polifarmacología
@es
Polypharmacology
@en
polypharmacologie
@fr
type
label
Polifarmacologia
@ca
Polifarmacología
@es
Polypharmacology
@en
polypharmacologie
@fr
altLabel
Polifarmacologia
@es
prefLabel
Polifarmacologia
@ca
Polifarmacología
@es
Polypharmacology
@en
polypharmacologie
@fr
P486
P6366
P279
P486
P6366
2778154635